Clinical Trial Update: A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

View source ↗

Summary

Clinical trial update describing kidney transplantation patients converted from twice-daily tacrolimus (Prograf) to once-daily tacrolimus (Advagraf); the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• Advagraf (tacrolimus)
• Prograf (Tacrolimus)

Snippet

Sponsor: Astellas Pharma S.A.S. | Conditions: Renal Transplantation | Status: COMPLETED